Instructions for use Erebra sublingual tablets 0.02 g blister No. 20
Composition
active ingredient: dry extract of hiporamine (sea buckthorn leaves dry extract, Hippophae rhamnoides L.), (6.5:1), extractant ethanol – 70%) with a content of the sum of tannins in terms of casuarinine and absolutely dry matter of 60%);
1 tablet contains 20 mg of dry extract of hyporamine;
excipients: sucrose, cocoa powder (cocoa bean powder), vanillin, carmellose sodium, calcium stearate.
Dosage form
The tablets are round, biconvex, with a score, from light gray or light gray with a pink tint to light brown with darker and lighter inclusions.
Pharmacotherapeutic group
Other antiviral agents. ATX code J05A X.
Pharmacological properties
Hyporamine - a dry purified extract from the leaves of sea buckthorn (Hippophае rhamnoides L.) - is a polyphenol complex of haloellagotannins, the biologically active components of which are hydrolyzed tannins, which have common structural elements in the form of glucose-halo and hexahydroxyphenol residues.
Hyporamine exhibits high antiviral activity against various strains of influenza A and B viruses, adenoviruses, paramyxoviruses, herpes simplex viruses, herpes zoster, cytomegalovirus (CMV), respiratory syncytial virus (RSV). The inhibitory effect of the drug on the reproduction of viruses is manifested in the early stages of their development. One of the mechanisms of action of the drug is the inhibitory effect on viral neuraminidase.
Hyporamine induces interferon production in blood cells in vitro and increases the content of interferon in the blood of patients.
The drug also has a moderate antimicrobial effect in vitro against gram-positive (Staphylococcus aureus) and gram-negative bacteria (Escherichia coli, Proteus vulgaris, Pseudomonas aeruginosa), tuberculous mycobacteria (Mycobacterium tuberculosis), candida (Candida albicans) and some mycelial fungi (Microsporum canis).
Indication
As a therapeutic and prophylactic agent for influenza (A and B), parainfluenza, respiratory syncytial virus, viral, adenovirus and other acute respiratory viral infections; tonsillitis occurring against the background of acute respiratory viral diseases (complex therapy); for acute and recurrent forms of herpes simplex of extragenital and genital localization, for shingles, chickenpox and cytomegalovirus infection.
Contraindication
Hypersensitivity to the components of the drug. Sucrase/isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption.
Interaction with other medicinal products and other types of interactions
The drug can be used in combination with other medications (antimicrobials, synthetic antivirals, and symptomatic therapy).
Application features
It is necessary to prescribe it at the earliest stages of the disease.
Use with caution in diabetes.
1 tablet of the drug contains 0.5539 g of carbohydrates, which corresponds to 0.046 XO. Patients with diabetes should take the drug only after consulting a doctor.
Use during pregnancy or breastfeeding
Safety and efficacy have not been established, so the drug should not be used during pregnancy.
The ability to influence the reaction speed when driving or working with other mechanisms
Does not affect.
Method of administration and doses
The drug is taken orally.
Treatment.
Keep 1 tablet in the mouth until completely dissolved. Adults and children aged from
Children aged 12 years should be prescribed 1 tablet 4-6 times a day, children aged 6-12 years - 1 tablet 3-4 times a day, children aged 3-6 years - ½ tablet 2-4 times a day.
Duration of use is from 3 days to 3 weeks, depending on the nosological form of the disease.
For influenza - at least 3 days; for parainfluenza, respiratory syncytial virus, adenovirus infections, tonsillitis occurring against the background of acute respiratory viral diseases (complex therapy) and other acute respiratory viral infections - at least 5 days.
In chickenpox, shingles, herpesvirus and cytomegalovirus infections, the duration of use depends on the severity of the process and is 3-10 days for mild forms of the disease. In severe and recurrent forms of the disease, the minimum course of treatment is 2-3 weeks. Repeated courses of treatment are advisable.
For prevention during a flu outbreak, take the drug according to age-appropriate dosages for 3 days to 3 weeks.
Children
The drug should be used in children over 3 years of age.
Overdose
To date, no cases of drug overdose have been registered.
With prolonged use in doses exceeding those specified in the instructions, increased blood clotting is possible.
Treatment is symptomatic.
Side effects
Allergic reactions are possible.
If any adverse reactions occur, treatment should be discontinued and a doctor should be consulted.
Expiration date
4 years.
This medicine should not be used after the date indicated on the package.
Storage conditions
Store in the original packaging and out of the reach of children at a temperature not exceeding 25 °C.
Packaging
10 tablets in a blister; 1 or 2 blisters in a cardboard pack; 20 tablets in a blister; 1 blister in a cardboard pack.
Vacation category
Without a prescription.
Producer
Technolog PJSC.
Address
Ukraine, 20300, Cherkasy region, Uman city,
8, Stara Prorizna St.
